Fervo Energy, Geothermal Startup, Sets Terms for Nasdaq IPO
Geothermal developer Fervo Energy will begin trading Wednesday on the NASDAQ under ticker FRVO after raising its offering to 70 million shares priced at $25 to $26 each, targeting a $7.4 billion valuation. The company has deployed its horizontal drilling technology in Nevada and is building the much larger Cape Station project in Utah.
app.buzzsumo.comU.S. history. 8 billion in its IPO.
4 billion. 6 million shares at around $21 to $24 each earlier this year, the line was reportedly out the door. Fervo uses horizontal drilling and fiber-optic sensing to tap geothermal sources previously out of reach.
The company has successfully deployed its technology in Nevada, producing enough clean energy to power about 2,600 homes. It is building the Cape Station facility in Utah that would produce more than 100 times the electricity of the Nevada deployment. Cape Station is slated to go online later this year.
Fervo has secured hundreds of millions of dollars in additional financing for Cape Station. The prospect has drawn high-profile investors including Bill Gates’s Breakthrough Energy Ventures and Alphabet, which has signed contracts to supply power to its data centers. Fervo hopes of cutting the price of geothermal from $7,000 to $3,000 per kilowatt.
“Innovation is allowing these technologies to cover a wider variety of sites,” said Zainab Gilani, a geothermal analyst with research firm Cleantech Group. The IPO comes against a backdrop of surging electricity demand driven by data centers for artificial intelligence. The Iran war has only exacerbated energy prices.
Grist reported that some view the offering as a promising sign for clean tech despite recent policy shifts. The Inflation Reduction Act was signed in 2022 by former President Joseph Biden. The Inflation Reduction Act included billions for solar, wind, geothermal and other green technologies.
But since returning to office, President Donald Trump and Congress have largely dismantled that legislation, rolled back much of the nation’s wind development, and pushed fossil fuel as the answer to the country’s energy woes. Earlier this year, Amazon-backed nuclear reactor developer X-Energy raised $1 billion with its public offering and is valued at more than $9 billion.
Grist reported that Jigar Shah, a former senior official at the Department of Energy under Biden and now managing partner at the investment firm Multiplier, said there is a level of confidence coming to the clean tech sector. “There is a level of confidence coming to our sector, which I think is great,” Shah said. “For a long time, our space has acted as if we’re alternative energy.
Climate economist Gernot Wagner at Columbia Business School called the IPO significant. “This is a very, very big deal. ” Rob Gramlich, president of Grid Strategies, offered a more tempered view on the technology’s immediate prospects.
“They’re just not here yet on any large scale.
Key Facts
Story Timeline
4 events- 2022
Former President Joseph Biden signed the Inflation Reduction Act including billions for geothermal
1 sourceGrist - Earlier this year
Fervo announced plans to sell 55.6 million shares at $21-$24; X-Energy raised $1 billion in public offering
1 sourceGrist - This week
Fervo boosted IPO target to 70 million shares at $25-$26, valuing company at $7.4 billion
1 sourceGrist - 2026-05-13
Fervo Energy to begin trading on NASDAQ under ticker FRVO on Wednesday morning
1 sourceGrist
Potential Impact
- 01
Demonstrates continued private financing for clean energy projects despite federal policy rollback
- 02
Potential to draw investor attention to advanced geothermal beyond niche community
- 03
May accelerate cost reductions and site applicability for geothermal as 2040-2050 grid option
Transparency Panel
Related Stories
NprWHO Director Visits Congo as Ebola Outbreak Spreads
The head of the World Health Organization arrived in Kinshasa to support efforts against a rare Ebola strain. Health workers face equipment shortages, community distrust, and armed conflict in affected provinces.
medpagetoday.comFDA Panel Recommends XFG Variant for Fall Covid Shots
Replimune will submit an application to the FDA for the third time. Pfizer and Innovent Biologics reached a collaboration agreement valued at up to $10.5 billion.
Benzinga Publishes Article on Biotech Stocks During Pandemic Recovery
Benzinga published an article titled 'Best Biotech Stocks Right Now' that addresses the sector's position during global recovery from the pandemic. The piece notes government institutions and professional traders are focusing on biotech companies for vaccine and booster developme…